March 10, 2023 06:52 AM ESTUpdated 08:21 AM
Peer Review

Bio­gen looks to its bench to re­place chair­man Pa­padopou­los; Lil­ly, Ab­b­Vie gene ther­a­py part­ner makes CSO hire

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Car­o­line Dor­sa will chair the board at Bio­gen af­ter its an­nu­al meet­ing in June, the com­pa­ny re­vealed on Wednes­day. Last …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times